UNSPSC 51171855: Clebopride

This classification denotes a dopamine antagonist with the molecular formula C20H24ClN3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I0A84520Y9, chemically known as benzamide, 4-amino-5-chloro-2-methoxy-n-(1-(phenylmethyl)-4-piperidinyl)- but generally known as clebopride, which bears US NIH Compound Identifier 2780. European Medicines Agency schedules Clebopride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06646MIG.

UNSPSC 51171855 Clebopride, a Commodity code, does not align with the state and local opportunities posted under this classification. The code nominally names a specific pharmaceutical compound (clebopride, a prokinetic agent), yet the three recent solicitations tagged to it address offender drug testing services, direct-to-manufacturer prescription program design, and multi-source generic pharmaceuticals and over-the-counter products — none of which involve clebopride procurement or use. The mismatch suggests either miscoding in the state and local procurement databases or a fundamental classification misalignment between the UNSPSC taxonomy and how issuing bodies are tagging pharmaceutical-related solicitations.

The recent opportunities show activity among Texas state health agencies (Texas HHS Commission), county-level community supervision departments (Collin County), and multi-state cooperative purchasing vehicles (MMCAP, administered by Minnesota), with responses due between April and July 2026. Collin County's RFP for offender specimen collection and drug testing services (due July 23, 2026, estimated value $600,000) and MMCAP's generic pharmaceuticals cooperative contract (due March 26, 2026, serving Oregon and other participating states) represent the most concrete recent procurements. The Texas HHS RFI on direct-to-manufacturer prescriptions (closed April 3, 2026) functions as market intelligence rather than a binding solicitation. The code shows little relevant recent activity tied to clebopride specifically; business development teams should verify correct UNSPSC coding with issuing bodies before pursuing opportunities listed under this classification.